COVID-19 Vaccine Market Revenue Forecast 2022 (January 2022)
Download Airfinity's COVID-19 Vaccine Market Forecast 2022, released on 21 January 2022.
The COVID-19 vaccine market for non-Chinese vaccines is expected to reach $65.6B in 2021 and grow to $84.9B in 2022, a 29% growth. The market will be dominated by mRNA vaccines, making Pfizer/BioNTech and Moderna the two best selling medical products in 2022.
The COVID-19 vaccine market for non-Chinese vaccines is expected to reach $65.6B in 2021 and grow to $84.9B in 2022, a 29% growth. The market will be dominated by mRNA vaccines, making Pfizer/BioNTech and Moderna the two best selling medical products in 2022.
For press enquiries, please contact press@airfinity.com